Search

Your search keyword '"Bando H"' showing total 1,397 results

Search Constraints

Start Over You searched for: Author "Bando H" Remove constraint Author: "Bando H"
1,397 results on '"Bando H"'

Search Results

1. Integrated Electronic Health Record of Multidisciplinary Professionals Throughout the Cancer Care Pathway: A Pilot Study Exploring Patient-Centered Information in Breast Cancer Patients

2. Anatomic and functional outcomes of 25-gauge vitrectomy for repair of eyes with rhegmatogenous retinal detachment complicated by proliferative vitreoretinopathy

3. Hyperautofluorescent ring in eyes with macular holes

4. Faster recovery after 25-gauge microincision vitrectomy surgery than after 20-gauge vitrectomy in patients with proliferative diabetic retinopathy

7. Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with metastatic colorectal cancer

9. Analysis of Local Distribution and Residence Time of Nintedanib in Fibrotic Lung Tissue Using Mass Spectrometry Imaging

10. The Effect of Novel Autotaxin Inhibitor, 2-carba Cyclic Phosphatidic Acid, in Lung Fibrosis

11. VOLTAGE-2: multicenter phase II study of nivolumab monotherapy in patients with mismatch repair-deficient resectable locally advanced rectal cancer

12. Corrigendum to “Comprehensive clinical and molecular characterization of claudin 18.2 expression in advanced gastric or gastroesophageal junction cancer”

13. Phase III trial of short-course radiotherapy followed by CAPOXIRI versus CAPOX in locally advanced rectal cancer: the ENSEMBLE trial

14. Absence of the 1/8 -anomaly in oxygen isotope effect on YBa$_{2}$Cu$_{3}$O$_{y}$

16. Low-temperature specific heat for ferromagnetic and antiferromagnetic orders in CaRu1-xMnxO3

17. An Isotopic Fingerprint of Electron-Phonon Coupling in High-Tc Cuprates

18. Isotopic Fingerprint of Electron–Phonon Coupling in High-Tc Cuprates

19. Interplay of electron-lattice interactions and superconductivity in Bi2Sr2CaCu2O8+d

20. Orbital selectivity of the kink in the dispersion of Sr2RuO4

21. Antiferromagnetic Order in Disorder-Induced Insulating Phase of SrRu_{1-x}Mn_xO_3 (0.4<x<0.6)

22. Spectroscopic Signatures on Increase in Charge-Density-Wave Potential of 1{\em T}-TaS$_{1.2}$Se$_{0.8}$

23. 125MO Long-term outcomes of neoadjuvant trastuzumab emtansine + pertuzumab (T-DM1+P) and docetaxel + carboplatin + trastuzumab + pertuzumab (TCbHP) for HER2-positive primary breast cancer: JBCRG20 study (Neo-peaks)

24. Efficacy and safety of trastuzumab, lapatinib, and paclitaxel neoadjuvant treatment with or without prolonged exposure to anti-HER2 therapy, and with or without hormone therapy for HER2-positive primary breast cancer: a randomised, five-arm, multicentre, open-label phase II trial

25. 349P Analysis of plasma angiogenesis factors on the efficacy of 2nd-line (2L) chemotherapy (chemo) combined with angiogenesis inhibitors (AIs) in metastatic colorectal cancer (mCRC): Results from GI-SCREEN CRC Ukit study

26. 442TiP A multicenter phase II clinical study evaluating the efficacy and safety of perioperative encorafenib, binimetinib plus cetuximab combination treatment in patients with surgically resectable BRAF V600E-mutant colorectal oligometastases (NEXUS)

27. 1211P A multicenter phase II study of atezolizumab monotherapy following definitive chemoradiotherapy for unresectable locally advanced esophageal squamous cell carcinoma (EPOC1802)

29. PD-13 Plasma RAS dynamics and efficacy of anti-EGFR rechallenge in patients with RAS/BRAF wild-type metastatic colorectal cancer: REMARRY and PURSUIT trials

30. P-80 A multicenter randomized phase II study comparing CAPOXIRI plus bevacizumab and FOLFOXIRI plus bevacizumab as the first-line treatment for metastatic colorectal cancer: A safety analysis of the QUATTRO-II study

47. Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis treatment and follow-up of patients with localised colon cancer

49. Randomized trial of preoperative docetaxel with or without capecitabine after 4 cycles of 5-fluorouracil–epirubicin–cyclophosphamide (FEC) in early-stage breast cancer: exploratory analyses identify Ki67 as a predictive biomarker for response to neoadjuvant chemotherapy

Catalog

Books, media, physical & digital resources